Abstract Cannabis is the third most used psychoactive substance worldwide. The legal status of cannabis is changing in many Western countries, while we have very limited knowledge of the public health impact of cannabis-related harms. There is a need for a summary of the evidence of harms and risks attributed to cannabis use, in order
Soaring rates of vaping among young people and associated problems have resulted in great urgency and important challenges for policymakers. Despite the urgency, policies should be evidence-based and thoughtfully designed. They require effective, collaborative, and well-funded enforcement by federal and state governments. Policymakers should aim to reduce vaping among young people while maintaining avenues to
Regulating Vaping — Policies, Possibilities, and Perils (NEJM) Read More »
PMID: 32187114 DOI: 10.1097/ADM.0000000000000638 Abstract Objectives: Cannabis is a known teratogen. Data availability addressing both major congenital anomalies and cannabis use allowed us to explore their geospatial relationships. Methods: Data for the years 1998 to 2009 from Canada Health and Statistics Canada was analyzed in R. Maps have been drawn and odds ratios, principal component analysis, correlation matrices, least
First published:20 February 2020 Abstract – Findings: the initiation of recreational cannabis commercialization was associated with 5.06–5.80 more exposures per 1 000 000 population per quarter (67–77% increase relative to the pre‐legalization average), depending on the composition of comparison states. The increase associated with commercialization was higher among minors than adults (7.97–9.53 versus 3.83–4.21 more exposures), higher among
The study finds that marijuana commercialization was associated with a 67-77% increase in marijuana exposure calls to poison control centers, with a dramatic rise in exposures among those below the age of 21. According to the study, had all 50 states and DC commercialized marijuana in 2017, the total number of exposures nationwide would have
Abstract – Background: E-cigarettes are battery-operated devices that heat a liquid and deliver an aerosolized product to the user. Pulmonary illnesses related to e-cigarette use have been reported, but no large series has been described. In July 2019, the Wisconsin Department of Health Services and the Illinois Department of Public Health received reports of lung injury
Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report Read More »
Download PDF Copy By Dr. Liji Thomas, MD Mar 8 2020 From August 2019 to date, over 2,700 patients have been reported with e-cigarette, or vaping, associated lung injury (EVALI) in all the states of the US. Study – Severe Lung Injury Associated With Use of e-Cigarette, or Vaping, Products—California, 2019. Image Credit: Shannon Laura / Shutterstock The study
Study looks at lung injury and vaping THC and vitamin E acetate Read More »
